TipRanks
Advertisement
Advertisement

DE:ECQ0 Stock Latest News

Neurizon updates investors on NUZ-001 strategy and plans ALS trial milestones
Company AnnouncementsNeurizon updates investors on NUZ-001 strategy and plans ALS trial milestones
2d ago
FDA Feedback Positions Neurizon’s ALS Trial as Potentially Registrational
PremiumCompany Announcements
FDA Feedback Positions Neurizon’s ALS Trial as Potentially Registrational
3d ago
Neurizon Director Boosts Shareholding in On-Market Purchase
PremiumCompany Announcements
Neurizon Director Boosts Shareholding in On-Market Purchase
22d ago
Neurizon Therapeutics Redeems 1 Million Convertible Notes Without Conversion
PremiumCompany Announcements
Neurizon Therapeutics Redeems 1 Million Convertible Notes Without Conversion
23d ago
Neurizon Cuts Convertible Notes and Locks In Standstill as HEALEY ALS Trial Funding Secured
PremiumCompany Announcements
Neurizon Cuts Convertible Notes and Locks In Standstill as HEALEY ALS Trial Funding Secured
28d ago
Neurizon Therapeutics Seeks ASX Quotation for 7.4 Million New Shares
PremiumCompany AnnouncementsNeurizon Therapeutics Seeks ASX Quotation for 7.4 Million New Shares
28d ago
NIH Backs Neurizon’s NUZ-001 ALS Access Program With Multimillion-Dollar Grant
Premium
Company Announcements
NIH Backs Neurizon’s NUZ-001 ALS Access Program With Multimillion-Dollar Grant
30d ago
Neurizon names seasoned pharma executive Chris Bremer as CEO ahead of key ALS trial readout
Premium
Company Announcements
Neurizon names seasoned pharma executive Chris Bremer as CEO ahead of key ALS trial readout
1M ago
Neurizon Therapeutics Expands ASX Quoted Share Base
PremiumCompany Announcements
Neurizon Therapeutics Expands ASX Quoted Share Base
1M ago
Neurizon Therapeutics files ASX governance disclosure for 2026
PremiumCompany Announcements
Neurizon Therapeutics files ASX governance disclosure for 2026
1M ago
Neurizon Therapeutics Narrows Loss and Strengthens Balance Sheet in 2026
PremiumCompany Announcements
Neurizon Therapeutics Narrows Loss and Strengthens Balance Sheet in 2026
1M ago
Neurizon Therapeutics Issues Large Tranche of Unquoted Incentive Securities
PremiumCompany Announcements
Neurizon Therapeutics Issues Large Tranche of Unquoted Incentive Securities
2M ago
Neurizon strengthens Elanco alliance with appointment of new Board observer
PremiumCompany AnnouncementsNeurizon strengthens Elanco alliance with appointment of new Board observer
2M ago
Neurizon accelerates ALS trial and secures supply deal as funding base strengthens
Premium
Company Announcements
Neurizon accelerates ALS trial and secures supply deal as funding base strengthens
2M ago
Neurizon Secures $17.5m Non-Dilutive R&D Financing to Fund ALS Trial
Premium
Company Announcements
Neurizon Secures $17.5m Non-Dilutive R&D Financing to Fund ALS Trial
2M ago
Neurizon to Outline ALS Trial Progress and NUZ-001 Strategy at Melbourne Investor Briefing
PremiumCompany Announcements
Neurizon to Outline ALS Trial Progress and NUZ-001 Strategy at Melbourne Investor Briefing
2M ago
Neurizon director Marcus Hughes lifts stake with June share purchases
PremiumCompany Announcements
Neurizon director Marcus Hughes lifts stake with June share purchases
3M ago
Neurizon Therapeutics Plans Equity Placement of 461,538 Shares
PremiumCompany Announcements
Neurizon Therapeutics Plans Equity Placement of 461,538 Shares
3M ago
Neurizon options lapse as 5 million NUZAP securities expire unexercised
PremiumCompany Announcements
Neurizon options lapse as 5 million NUZAP securities expire unexercised
3M ago
Neurizon strengthens NUZ-001 ALS case with new mechanistic data at BIO 2026
PremiumCompany AnnouncementsNeurizon strengthens NUZ-001 ALS case with new mechanistic data at BIO 2026
4M ago
Neurizon Therapeutics Seeks ASX Quotation for 9.7 Million New Shares
Premium
Company Announcements
Neurizon Therapeutics Seeks ASX Quotation for 9.7 Million New Shares
4M ago
Neurizon Secures Long-Term Elanco Supply Deal for Lead ALS Drug NUZ-001
Premium
Company Announcements
Neurizon Secures Long-Term Elanco Supply Deal for Lead ALS Drug NUZ-001
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >